Affiliation:
1. N.N. Blokhin National Medical Russian Research Center of Oncology, Ministry of Health of Russia
2. Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Abstract
Skin cancer is the second most common tumor among non-melanoma malignant skin neoplasms, accounting for 20 % of cases. In the Russian federation in 2022, this pathology was identified in 79,124 people. The peak incidence occurs in the age range of 60–70 years. Considering the increasing life expectancy, the incidence of skin cancer is expected to rise. Despite the fact that regional metastases occur in 0.3–16 % of cases, the risk of metastasis can increase up to 48 % depending on high-risk factors. Since the presence of regional metastases is a key prognostic factor, special attention should be given to preventive interventions in the areas of regional metastasis.
Publisher
Publishing House ABV Press
Reference69 articles.
1. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166(5):1069–80. DOI: 10.1111/j.1365-2133.2012.10830.x
2. Leiter U., Eigentler T., Garbe C. Epidemiology of skin cancer. Sunlight, vitamin D and skin cancer. NY: Springer, 2014. Pp. 120–140.
3. The state of cancer care for the Russian population in 2022. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of the Russian Federation, 2023. 250 p. (In Russ.).
4. Stratigos A., Garbe C., Lebbe C. et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015;51(14):1989–2007. DOI: 10.1016/j.ejca.2015.06.110
5. Trakatelli M., Ulrich C., del Marmol V. et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007;156(3):1–7. DOI: 10.1111/j.1365-2133.2007.07861.x